ロード中...
Cellular and Molecular Chaperone Fusion Vaccines: Targeting Resistant Cancer Cell Populations
Molecular chaperone-based vaccines offer a number of advantages for cancer treatment. We have discussed the deployment of a vaccine prepared by gentle isolation of Hsp70 from tumor dendritic cell fusions (Hsp70 fusion vaccine). The vaccine was highly effective in triggering specific T cell immunity...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4100618/ https://ncbi.nlm.nih.gov/pubmed/23682824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/02656736.2013.792126 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|